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Silver nanoparticles are the most important nanoparticles in connection with the antimicrobial effect.
Nowadays, the green synthesis of various types of nanoparticles is rapid, effective and produce
less toxic nanoparticles often with specific properties. In our experiment we have developed and
described in details various types of silver nanoparticles synthesized chemically or by the green
synthesis. Nine different silver nanoparticles were synthesized, three by citrate method at differ-
ent pHs (8; 9; 10), four using gallic acid at alkaline pHs (10; 11), and two by green synthesis
using green tea and coffee extracts, both at pH 9. Characterisation of silver nanoparticles was per-
formed using dynamic light scattering, scanning electron microscopy, and ultraviolet–visible absorp-
tion spectroscopy. Silver nanoparticles prepared by green synthesis showed the highest antioxidant
activity and also ability for quenching of free radicals. Antibacterial activity of silver nanoparticles
was determined on bacterial cultures such as Staphylococcus aureus and Escherichia coli. Silver
nanoparticles synthesized using green tea and coffee extracts showed the highest antibacterial
activity for both bacterial strains. Minimal inhibition concentration for both strains was found to be
65 M at each silver nanoparticle synthesized using green synthesis.
Keywords: Silver Nanoparticles, Antioxidant Activity, Antimicrobial Activity, Green Synthesis.
1. INTRODUCTION
Due to the increasing bacterial resistance to classic antibi-
otics, the investigations on the antibacterial activity of
silver nanoparticles have increased over the last few
decades.12 The antibacterial activity of silver species
has been well known since ancient Greece2–4 and it has
been demonstrated that, in low concentrations, silver is
non-toxic to human cells.5 Currently, the investigation
of this phenomenon has regained importance due to the
increase of bacterial resistance to antibiotics, caused by
their overuse.6
Antibacterial activity of the silver-containing materials
can be used, for example, in medicine to reduce infec-
tions in burn treatment and arthroplasty, as well as to
∗Author to whom correspondence should be addressed.
prevent bacteria colonization on prostheses, catheters, vas-
cular grafts, dental materials, stainless steel materials, and
human skin.78 Contrary to bactericide effects of ionic sil-
ver, the antimicrobial activity of colloid silver nanoparti-
cles is influenced by the dimensions of the particles. The
smaller the particles, the greater the antimicrobial effect
is, this is due to better penetration of smaller nanoparti-
cles (1–10 nm) into bacterial cells.9 Silver nanoparticles
exhibiting antimicrobial activity have been synthesized by
utilizing different methodologies.2–510 The most common
method to synthesize silver nanoparticles is the chemi-
cal reduction of a silver salt solution by a reducing agent
such as NaBH4, citrate, and ascorbate. The use of a strong
reductant e.g., chemical compound such as borohydride,
results in the formation of small particles (20–45 nm).
On the other hand the use of citrate, a weaker reductant,
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Figure 1. Proposed mechanisms of action of silver nanoparticles AgNPs (or Ag+ coming from AgNPs) on bacteria. (A) AgNPs penetrate the bacterial
cell wall and may bind to the phospholipid bilayer of the cytoplasmic membrane; (B) AgNPs may bind the bacterial DNA with subsequent disrupting
of DNA replication; (C) AgNPs may impair the ability of ribosomes to transcribe messenger RNA; (D) AgNPs may bind to the sulfhydryl group of
the cytochrome b. Adopted and modified according to Ricco and Assadian.8
resulted in a slower reduction rate, with a wide distribution
size varying from 20–170 nm.2
Inorganic conventional synthesis of nanoparticles using
physical methods are used for preparation of antibacte-
rial nanoparticles. This process is demanding for chem-
icals, instruments and energy. In recent years, the main
goal of research has been focused on the development
of efficient methods of organic chemistry for synthesis of
metallic nanoparticles. Often used approach is the pro-
duction of metal nanoparticles using organisms such as
plants. Nanoparticles produced by plants are stable and
the rate of synthesis is faster than in the case of microor-
ganisms which is one of the other possibilities of green
synthesis.11 The green biosynthesis is based on the reduc-
tion of metal ions to nanoparticles by biomolecules present
in plant extracts. For green biosynthesis is possible to
use plant extracts and live plants.12 Biogenic AgNPs are
functionalized with phytochemical coating, rendering them
more biologically active as compared with chemically syn-
thesized AgNPs.13 Eco-friendly plants containing proteins,
which act as both reducing and capping agents form a sta-
ble and shape-controlled AgNPs. Mechanism of antibacte-
rial effect of AgNPs modified by surfactants polymers is
discussed in terms of its interaction with cell membrane
against Gram-positive and Gram-negative bacteria.10 The
intensity of antibacterial effect depends on the type of cell
membrane.
The actual bactericide mechanism of silver nanoparti-
cles is not well known. Some researchers support the idea
that silver species release Ag+ ions that interact with the
thiol groups within the proteins in the bacteria, affect-
ing there application of DNA.7 It has also been reported
that Ag+ ions either uncouple the respiratory chain from
oxidative phosphorylation or collapse the proton-motive
force across the cytoplasmic membrane.3 Silver nanopar-
ticles interactions with bacteria depend on the size and
shape of the nanoparticles.259 Several studies have been
reported to explain the inhibitory effect of silver on bac-
teria, and it is generally believed that silver ions interact
with proteins by reacting either with the thiol groups of
methionine or cysteine amino acids of the active site of
the enzymes, leading to the inactivation of the proteins.
In particular, Feng et al.14 reported that silver ions affect
the DNA replication capability, which in turn induces the
inactivation of bacterial proteins (Fig. 1).
In this work, we used different approaches for silver
nanoparticles’synthesis. We utilized the classical citrate
method, then reduction using gallic acid at alkaline pH,
and finally green synthesis using green tea and coffee
extracts. The obtained nanoparticles were characterized
using dynamic light scattering (DLS), scanning elec-
tron microscopy (SEM), and ultraviolet-visible (UV-vis)
absorption spectroscopy. An antioxidant approach and
antibacterial activity test was conducted to observe differ-
ences in antibacterial activity among the various types of
silver nanoparticles.
2. EXPERIMENTAL DETAILS
2.1. Chemical
All the chemicals used in this study (AgNO3, NaBH4,
gallic acid, trisodium citrate dihydrate, NaOH) were pur-
chased from Sigma-Aldrich (St. Louis, MO, USA) in ACS
purity. NaBH4 was purchased from (Merck, Darmstadt,
Germany), 25% NH4OH water solution was purchased
from Lach-Ners.r.o. (Neratovice, Czech Republic). Deion-
ized water was prepared using reverse osmosis equipment
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Aqual 25 (Brno, Czech Republic). Deionized water was
further purified by using a MiliQ Direct QUV apparatus
equipped with a UV lamp. The resistance was 18 M.
The pH was measured using a pH meter WTW inoLab
(Weilheim, Germany).
2.2. Preparation of Silver Nanoparticles
2.2.1. AgNPs-A, B, C
Silver nanoparticles were prepared according to Wan
et al.15 with a minor modification. 500 L of 0.1 M
AgNO3 was mixed with 49 mL of distilled water. Then,
1650 L of 1% tri-sodium citrate was added dropwise.
Subsequently, 10 mL of 10 mM NaBH4 (A) or 10 mL of
5 mM NaBH4 (B) or 10 mL of 20 mM NaBH4 (C) were
added and the solution was stirred for 1 hour to change
the colour to yellow, indicating the formation of particles.
The resulting pH was as follows: for A 9.2, for B 7.7, and
for C 9.6.
2.2.2. AgNPs-D, E, F, G
100 mL of 0.001 M AgNO3 was mixed with 10 mL of gal-
lic acid (1 mg/mL) and the solution was stirred for 1 hour
to change the colour to yellow. The pH was then adjusted
with 1 M NaOH to 11.0 (D) or with NH4OH (25%) to
pH 10 (E) or with 1 M NaOH to pH 10 (F) or with
NH4OH (25%) to pH 11 (G).
2.2.3. AgNPs-H, I
2 g of green tea (H) or coffee (I) was dipped in 100 mL
of distilled water. The solution was heated to 80 C for
20 min (H) or for 5 min (I). The solution was then cooled
and filtered. The filtrate obtained was used as a reducing
agent. A 1:1 solution of 0.1 M AgNO3 was mixed with
the filtrate obtained. The mixed solution was allowed to
stir for 24 hours at room temperature.
2.3. Scanning Electron Microscopy
Structure of AgNPs was characterized by SEM. For doc-
umentation of the nanoparticles structure a MIRA3 LMU
(Tescan, Brno, Czech Republic) was used. This model is
equipped with a high brightness Schottky field emitter for
low noise imaging at fast scanning rates. The SEM was
fitted with In-Beam SE detector. An accelerating voltage
of 15 kV and beam currents about 1 nA gives satisfactory
results regarding maximum throughput. Magnification for
AgNPs 40 kX was used.
2.4. Dynamic Light Scattering
The average particle size and size distribution were
determined using dynamic laser light scattering with a
Malvern Zetasizer (NANO-ZS, Malvern Instruments Ltd.,
Worcestershire, U.K.). Nanoparticle distilled water solu-
tion of 1.5 mL (1 mg/mL) was put into a optically homoge-
neous square polystyrene cells and measured at a detector
angle of 173, a wavelength of 633 nm, a refractive
index of 0.30, a real refractive index of 1.59, and a
temperature 25 C.
The particle charge (-potential) was measured by the
microelectrophoretic method at 25 C in polycarbon-
ate cuvettes. Each value was obtained as an average
of five subsequent runs of the instrument with at least
20 measurements.
2.5. UV-Vis Spectrometry
The optical properties of nanoparticles were studied by
spectral analysis. The absorbance spectra of nanoparti-
cles were recorded within the range from 350 to 700 nm
using an UV-3100PC UV-VIS spectrophotometer (VWR,
Germany).
2.6. Cultivation of Staphylococcus aureus and
Escherichia coli
Staphylococcus aureus and Escherichia coli were obtained
from the Czech Collection of Microorganisms, Faculty
of Science, Masaryk University, Brno, Czech Republic.
Strains were stored in the form of a spore suspension in
20% v/v glycerol at −20 C. Prior to use, the strains
were thawed and the glycerol was removed by washing
with distilled water in this study. The composition of the
cultivation medium was described as follows: meat pep-
tone 5 g L−1, NaCl 5 g L−1, bovine extract 1.5 g L−1,
yeast extract 1.5 g L−1 (HIMEDIA, Mumbai, India), steril-
ized MilliQ water. The pH value of the cultivation medium
was adjusted at 7.4 before sterilization. Sterilization of
media was carried out at 121 C for 30 min in a sterilizer
(Tuttnauer 2450EL, Beit Shemesh, Israel). The prepared
cultivation media were inoculated with bacterial culture
into 25 mL Erlenmeyer flasks. After the inoculation, bac-
terial cultures were cultivated for 24 h on a shaker at
600 rpm and 37 C. Bacterial culture cultivated under
these conditions was diluted with cultivation medium to
OD600= 0.1 and used in the following experiments.
2.7. Determination of Antibacterial Properties
To determine the antimicrobial effect of silver nanopar-
ticles (AgNPs) the measurement of the inhibition zones
was performed. Agar surface in Petri dish was covered
with a mixture of 100 mL of 24 h culture of S. aureus
or E. coli in the exponential phase of growth, and 3 mL
of LB medium (Luria Bertani medium). Excess volume of
the mixture of the Petri dishes was aspirated. Petri dishes
were insulated against possible external contamination and
placed in a thermostat (Tuttnauer 2450EL, Beit Shemesh,
Israel) set at 37 C for 24 h. After 24 h of incubation, the
inhibition zones were measured and photographed in each
Petri dish.
To determine the antimicrobial effect of tested AgNPs
by the growth curve method the absorbance using the
apparatus Tecan Infinite 200 PRO (TECAN, Switzerland)
was measured. In the microplate S. aureus and E. coli
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was mixed with various concentrations of AgNPs or alone
as a control for the measurements. The concentrations of
AgNPs in samples A–G were 0, 1.25, 10, 40 and 160 M.
The concentrations of AgNPs in samples H and I were 0,
0.065, 0.52, 2.1 and 8.3 mM. Total volume of mixture in
the Greiner 96 well transparent microplate (Sigma Aldrich,
St. Louis, MO, USA) was always 300 L. The absorbance
was measured at wavelength 600 nm for 20 hours every
30 minutes.
2.8. Determination of Quenching of Artificial Radicals
Spectrophotometric measurements of oxidative stress were
carried out using an automated chemical analyser BS-200
(Mindray, Shenzhen, China). Reagents and samples were
placed on cooled sample holder (4± 1 C) and automati-
cally pipetted directly into plastic cuvettes. Incubation pro-
ceeded at 37.0±0.1 C. Mixture was consequently stirred.
The washing steps of pipetting needle with distilled water
(18 m) were carried out in the midst of the pipetting.
The instrument was operated using the BS-200 software.
2.8.1. N,N-Dimethyl-1,4-Diaminobenzene (DMPD)
Method
DMPD radical scavenging activity of AgNPs was per-
formed as follows: The compound N ,N -dimethyl-1,4-
diaminobenzene (DMPD) is converted in solution to a
relatively stable and coloured radical form (DMPD+) by
the action of ferric salt. After addition of a sample con-
taining antioxidants, DMPD+ radicals are scavenged and
as a result of this scavenging, the coloured solution is
decolourized.16
A 160 L volume of reagent (200 mM DMPD, 0.05 M
FeCl3, 0.1 M acetate buffer pH 5.25) was injected into a
plastic cuvette with subsequent addition of 4 L sample.
Absorbance was measured at 505 nm. Difference between
absorbance at the last (12th) minute and second minute of
the assay procedure was used for calculating the antiox-
idant activity. The percentage of radicals, that were not
scavenged, was measured.
2.8.2. Free Radicals (FR) Method
This method is based on the ability of chlorophyllin (the
sodium-copper salt of chlorophyll) to accept and donate
electrons with a stable change of maximum absorption.
This effect is conditioned by an alkaline environment and
the addition of a catalyst. A 150 L volume of reagent was
injected into a plastic cuvette with the subsequent addi-
tion of a 6 L sample. The absorbance was measured at
450 nm in the second minute of assay and for the last
(12th) minute. The difference between these two values is
considered as an outputting value.17
2.8.3. Statistic and Results Evaluation
Data were processed using MICROSOFT EXCEL®
(USA). Results are expressed as mean ± standard
deviation (S.D.) unless noted otherwise (EXCEL®). All the
obtained data are stored in the Ladys database.
3. RESULTS AND DISCUSSION
Three different approaches of AgNPs synthesis have been
applied. The first approach was the chemical synthesis
based on the reduction of Ag+ ions using NaBH4 at differ-
ent concentrations (samples A–C). The second approach
was the preparation of AgNPs with gallic acid at various
pH (samples D–G). The third approach was the prepara-
tion of AgNPs using green synthesis. For the green syn-
thesis we used green tea and coffee extracts which are
able to reduce Ag+ ions and induce nanoparticle forma-
tion (samples H–I). The obtained solutions are shown in
the Figure 2.
3.1. Characterization of AgNPs
The characterization of AgNPs is necessary for their
confirmation, determination of their size and stability
properties which could play a role in their antibacterial
activity. We used size measurement and Z-potential char-
acterization of colloidal state of the nanoparticle system
as well as scanning electron microscopy (SEM) to obtain
detailed AgNPs structure. The summary of obtained results
is shown in Figure 3. SEM depicts the spherical shape of
AgNPs as well as the formation of clusters. Samples A, F,
H and I show enhanced increase in surface charging which
could be the result of used reduction agent. Nanoparticle
size was determined using dynamic light scattering mea-
surement. From all samples, the size varies in the range
of 80–85 nm and it is clearly evident that the dependence
of the preparation conditions did not have an effect on the
particle size.
Measurement of the zeta potential (or charge density)
of samples provides important information for predicting
their binding capacity and stability. Generally, a higher
zeta potential than 30 or −30 mV indicate good stability of
the nanoparticles in the colloidal system. Our synthesized
nanoparticles show negative charge and the values of the
zeta potential are in the range of −225± 35 mV in all
cases A–I. Poor stability of colloidal system could lead
to slight nanoparticle agglomeration which was confirmed
by SEM.
3.2. The Spectral Analysis of AgNPs
UV-VIS spectroscopy of the prepared samples could pro-
vide information about the change of the sample spectra in
dependence of the preparation protocol. The synthesized
AgNPs in aqueous solution were monitored by record-
ing the absorption spectra at a wavelength range of 250–
650 nm (Fig. 4). Nanoparticles made of silver, strongly
interact with specific wavelengths of light and show the
unique optical properties. The change of the AgNPs spec-
trum, depends on their aggregation or formation of differ-
ent AgNPs. Thus, the variety of AgNPs formation could
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Figure 2. AgNPs formed by two ways of chemical synthesis using different reduction agents (A–C) NaBH4 and (D–G) gallic acid at various pH.
Samples H and I are AgNPs produced by the green synthesis using tea and coffee extracts. The preparation protocol for each AgNPs are shown in
materials and methods.
be attributed to electrons near each particle surface which
become delocalized and are shared amongst neighbouring
particles. In the case of samples A–B which were reduced
by NaBH4, it was obvious that a similar trend with the
absorbance maxima near 400 nm was obtained indicating
a good agreement with Deepak et al.18 Absorbance spectra
of samples D–G showed different trends. In the case of
sample D, a shift of absorbance maximum to the shorter
wavelength 351 nm is obvious while sample F shows a
shift of absorbance maximum to the longer wavelength
423 nm. Those values are opposite to what it would be
expected for a characteristic AgNPs spectra. Spectrum of
sample G shows two absorbance maximum peaks at 300
and 374 nm. A similar trend is visible for sample E, where
the absorbance maxima nearly correspond to the sample G.
AgNPs formed employing a green synthesis show different
absorbance spectra compared to other conventional meth-
ods of synthesis. Two characteristic absorbance maximum
peaks for sample H at 250 and 400 nm and for sample I at
280 and 508 nm can be observed. This unusual spectrum
Figure 3. Photographs of prepared AgNPs (A–I) obtained by SEM and their sizes determined using dynamic light scattering. Further details are
described in material and methods.
course of AgNPs could be caused by the incorporation of
reducing substances from coffee and tea extracts. It was
estimated, that the characteristic spectra of green synthe-
sized AgNPs vary in their dependence course of used plant
extract.19
3.3. Determination of the Quenching Activity
To determine the quenching activity of the tested AgNPs,
we choose an appropriate assay employing DMPD
method. This assay is based on the reduction of buffered
coloured solution of DMPD in acetate buffer and ferric
chloride. The procedure involves measurement of decrease
in absorbance of DMPD in the presence of scavengers
at its absorption maximum of 505 nm. The activity is
expressed as percentage reduction of DMPD.20 Graph
(Fig. 4(D)) shows the ability of AgNPs quenching DMPD
radicals expressed as percentage of radicals that were not
scavenged. Samples A–E show similar quenching activity
(75%) independently on the preparation process while F, G
(88, 93%) evinced weak ability for quenching of DMPD
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Figure 4. (A–C) UV-vis absorbance spectra of prepared AgNPs over the range from 250 to 650 nm. The concentration of analysed nanoparticles was
2 mg/mL. (D) Graph of DMPD radicals quenched by AgNPs (2 mg/mL) expressed as the percentage of remaining radicals. (E) Graph of antioxidant
activity of AgNPs (2 mg/mL) measured by FR method. Further details are described in the materials and methods section.
radicals. In contrary to chemically synthesized AgNPs, the
formed nanoparticles from coffee and tea extracts show
the highest quenching effects (70, 73%). These results
were confirmed by Free Radicals method (Fig. 4(E)) based
on reducing substrate by antioxidants accompanied by a
colour reaction. The results obtained clearly show that the
antioxidant potential of green synthesized AgNPs (sam-
ples H and I) compared to chemically synthesized AgNPs
is higher. Although, these methods for determination of
antioxidant activity slightly correlate, the samples F and G
show opposite trend that could be explained by different
reaction mechanism of both methods.
3.4. Antimicrobial Activity of AgNPs
Agar diffusion test have been used for testing antimicro-
bial activity of the AgNPs examined. The method evalu-
ates the inhibitory zones which depends on how effective
the AgNPs is at stopping the growth of the bacterium.
A stronger antimicrobial effect will create a larger zone,
because a lower concentration of the AgNPs is enough
to stop bacterial growth. Determination of the inhibition
zones’ sizes for S. aureus showed evident inhibitory effect
resulting from the application of AgNPs-G and AgNPs-H
with 10 mm inhibition zones. The samples A, B, F, I created
on Petri dishes with S. aureus inhibition zones which had
a size over a range from 1 to 4 mm. Figure 5(A) illustrates
the lack of inhibition effect to S. aureus for sections C, D
and E. Figure 5(B) shows antibacterial testing properties
of the same samples on bacterial strain E. coli. Inhibition
zones were created for samples B, C, G, H, I with sizes
2, 1, 3, 3, and 3 mm, respectively. Samples AgNPs-D and
AgNPs-E did not cause inhibition in either of the both bac-
terial strains. The summary of obtained results is shown
in Figure 5(C). The highest inhibition effect was shown in
samples AgNPs-G, H, I for both bacterial strains.
Results obtained from measurement of inhibition zones
were supported by results from growth curve method
after AgNPs A–I samples treatment. The highest inhibi-
tion effects were showed by AgNPs H, I which were
created by green synthesis (Figs. 6(A, B(h, i))). The con-
centrations 0.065, 0.52 and 2.1 mM causes totally inhi-
bition of both bacterial strains. The minimal inhibition
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Figure 5. Comparison of inhibition zones after application of circular discs on the Petri dish with (A) E. coli and (B) S. aureus with AgNPs-A, B,
C, D, E, F, G, H, I. (C) Graph of inhibition zones’ sizes and the comparison between antimicrobial properties of AgNPs on E. coli and S. aureus.
concentration (MIC) was determined to be 65 M for
AgNPs in H and I samples. High inhibition effect is caused
by higher concentration of AgNO3 entering into green syn-
thesis than concentration of AgNO3 entering into inorganic
synthesis. AgNPs samples illustrated from A–I used the
same concentration of AgNPs entering into inorganic syn-
thesis. In the S. aureus case, the concentration of AgNO3
entering into inorganic synthesis for samples AgNPs A, B,
D, F, G (Figs. 6A(a, b, d, f, g)) was determined to be
1.25 M for the MIC. The MIC results were in this case
very low which is suitable for the use of nanoparticles,
signalizing the degree of bacterial resistance to antibacte-
rial compound. The MIC values for E. coli were different
than for S. aureus. The low values of MIC concentration
Figure 6. The growth curves of bacterial cultures with samples of AgNPs A–I is showed in A(A–I) for S. aureus and in B(A–I) for E. coli. The
applications of AgNPs to bacteria was used in increasing concentrations of AgNO3 entering into synthesis. The graphs show inhibition effect of AgNPs
samples A–G in different concentrations (A, B(A–G)): • S. aureus (A), E. coli (B), • 1,25 M, • 10 M, • 40 M and • 160 M of AgNO3. The
graphs on A, B(H, I) show inhibition effect of AgNPs H and I in concentrations: • Control S. aureus (A), control E. coli (B), • 0,065 mM, • 0,52 mM,
• 2,1 mM and • 8,3 mM of AgNO3.
1.25 M in E. coli case were associated with the samples
AgNPs B, D, E, F. The sample AgNPs G causes totally
inhibition both of S. aureus and E. coli at 160 M con-
centration (Fig. 6(A), (B)–(g)).
The differences of AgNPs samples with antibacterial
properties between the bacterial strains are caused by the
cell wall diversity of gram-positive S. aureus and gram-
negative E. coli. Gram-negative E. coli exhibits higher
resistance than gram-positive S. aureus. A higher inhi-
bition effect of AgNPs to S. aureus is important due
to its presence in skin surface and in infected wounds.
S. aureus is a bacteria that could be present in skin
wounds. It can be easily found in hospitals where the
growth of these particular bacteria in infectious diseases
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can cause severe complications to the patients. Frequently,
the use of antibiotics in hospitals leads to bacterial changes
such as the emergence of secondary antibiotic resistance.
The most widespread resistant bacteria is methicillin-
resistant S. aureus (MRSA). MRSA is the most common
cause of incurable infections in hospital departments. Sil-
ver nanoparticles can be used as an appropriate antibacte-
rial tool to prevent bacterial resistance forming.
Several studies indicate the dependence of AgNPs
size and the antibacterial effect on ubiquitous pathogenic
organisms.2414 The strongest antibacterial effect was
found to be in small nanoparticles over the range from
1 to 10 nm2. However, smaller AgNPs have been estimated
to be toxic for tissue cells. Our synthesized nanoparticles
show size circa 80 nm, and in the case of green synthesis
they have the higher antibacterial effect than chemically
synthesized AgNPs by various ways.21
4. CONCLUSION
In this manuscript, we have investigated the synthesis and
different properties of silver nanoparticles such as their
antioxidant capacity and potential of antibacterial effects.
AgNPs were synthesized chemically using different reduc-
tion agents such as NaBH4 and gallic acid at various pHs
(8–11). Moreover, the green synthesis of AgNPs via coffee
and tea extracts was also investigated. Those aforemen-
tioned synthetic (chemically and green) routes for AgNPs
were investigated and compared. From our results we can
observe that there is an obvious difference regarding spec-
tral properties of AgNPs which is dependent with the way
of synthesis. The green synthesized nanoparticles route
gave the highest antioxidant activity as well as a signifi-
cantly positive antimicrobial effect compared to the chem-
ical synthetic route.
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